Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [HEALTH]
3 clusters · 7 sources · 27 days · First seen · Last updated
Medical research on brain injury blood biomarkers
Overview
Medical researchers in the United States are developing blood-based methods to identify various forms of brain injury.
Initial research from the University of Pittsburgh focused on using two specific proteins, Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1), to detect traumatic brain injuries (TBI). This method aims to identify injuries when standard CT scans appear normal, potentially improving triage in emergency departments.
Subsequent findings from Washington University in St. Louis identified a protein fragment, eMTBR-tau243, which may assist in diagnosing chronic traumatic encephalopathy (CTE) in living patients. While preliminary, studies suggest that levels of this biomarker rise alongside the severity of CTE, though it may also be elevated in cases of Alzheimer’s disease.
Recent research published in JAMA indicates that this protein marker may correlate with advanced-stage CTE, a finding some researchers described as a potential “game changer.” While the test shows promise for identifying advanced pathology, it has not yet proven reliable for early-stage detection.
A systematic review and meta-analysis published in JAMA Network Open further noted that CTE pathology is rare in individuals without a history of contact sports, appearing in only 0.66% of community brain bank donors. However, researchers suggest that if these rates are extrapolated, more than 1 million Americans could be living with the disease, underscoring the necessity for effective diagnostic tools.
Entities
Washington University in St. Louis · Michael Alosco · Kanta Horie · Mass General Brigham · Journal of Neurosurgery
Timeline
-
[HEALTH] 5 sourcesResearchers identify potential blood test for living CTE diagnosis
New studies suggest a blood test could detect advanced-stage CTE in living patients, while research shows the disease is rare in those without contact sports history.
-
[HEALTH] 2 sourcesResearchers identify potential blood biomarker for CTE diagnosis
A preliminary study identifies the eMTBR-tau243 protein fragment in blood as a potential biomarker to help diagnose advanced CTE in living patients, a condition currently only diagnosable after death.
-
[HEALTH] 4 sourcesUniversity of Pittsburgh researchers develop blood test for hidden brain injuries
University of Pittsburgh researchers have identified blood biomarkers, specifically GFAP and UCH-L1, to detect traumatic brain injuries that may not be visible on initial CT scans.
Sources
dose.ca · hindi.sportskeeda.com · nbcsports.com · news-medical.net · news18.com · newsbytesapp.com · recentlyheard.com
This summary has been updated 1 time: see revision history